Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Checkpoint (Ncbi)

Index « Auteurs » - entrée « A R Crossman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
A R Cools < A R Crossman < A R Fernandes  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 13.
Ident.Authors (with country if any)Title
000117 (1999) B. Henry [Royaume-Uni] ; S H Fox ; D. Peggs ; A R Crossman ; J M BrotchieThe alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease.
000539 (2001) S H Fox [Royaume-Uni] ; B. Henry ; M P Hill ; D. Peggs ; A R Crossman ; J M BrotchieNeural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: evidence from the effects of the alpha(2) adrenoceptor antagonist idazoxan.
001088 (1992) I J Mitchell [Royaume-Uni] ; A R Crossman ; U. Liminga ; P. Andren ; L M GunneRegional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkey.
001118 (2005) Monty A. Silverdale [Royaume-Uni] ; S L Nicholson ; A R Crossman ; J M BrotchieTopiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.
001568 (1991) J M Brotchie [Royaume-Uni] ; I J Mitchell ; M A Sambrook ; A R CrossmanAlleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate.
001D24 (1991) T Z Aziz [Royaume-Uni] ; D. Peggs ; M A Sambrook ; A R CrossmanLesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
002539 (1991) I J Mitchell [Royaume-Uni] ; J M Brotchie ; G D Brown ; A R CrossmanModeling the functional organization of the basal ganglia. A parallel distributed processing approach.
002789 (1990) A R Crossman [Royaume-Uni]A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment.
003794 (1990) S. Boyce [Royaume-Uni] ; C E Clarke ; R. Luquin ; D. Peggs ; R G Robertson ; I J Mitchell ; M A Sambrook ; A R CrossmanInduction of chorea and dystonia in parkinsonian primates.
003798 (1990) I J Mitchell [Royaume-Uni] ; R. Luquin ; S. Boyce ; C E Clarke ; R G Robertson ; M A Sambrook ; A R CrossmanNeural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia.
003A92 (2013) Jose A. Obeso ; J. Guridi ; A. Nambu ; A R CrossmanMotor manifestations and basal ganglia output activity: the paradox continues.
004F05 (1998) N R Hughes [Royaume-Uni] ; A T Mcknight ; G N Woodruff ; M P Hill ; A R Crossman ; J M BrotchieKappa-opioid receptor agonists increase locomotor activity in the monoamine-depleted rat model of parkinsonism.
005014 (1998) A. Richter [Allemagne] ; J M Brotchie ; A R Crossman ; W. Löscher[3H]-2-deoxyglucose uptake study in mutant dystonic hamsters: abnormalities in discrete brain regions of the motor system.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "A R Crossman" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "A R Crossman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    A R Crossman
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024